BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19940772)

  • 1. The impact of societal changes on patterns of urolithiasis.
    Zilberman DE; Yong D; Albala DM
    Curr Opin Urol; 2010 Mar; 20(2):148-53. PubMed ID: 19940772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and urolithiasis.
    Asplin JR
    Adv Chronic Kidney Dis; 2009 Jan; 16(1):11-20. PubMed ID: 19095201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology of urolithiasis].
    Daudon M; Knebelmann B
    Rev Prat; 2011 Mar; 61(3):372-8. PubMed ID: 21563417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of stone disease.
    Porena M; Guiggi P; Micheli C
    Urol Int; 2007; 79 Suppl 1():37-46. PubMed ID: 17726351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of urolithiasis: a link between stone formation and diabetes mellitus?
    Zimmerer T; Weiss C; Hammes HP; Braun C; Hesse A; Alken P; Knoll T
    Urol Int; 2009; 82(3):350-5. PubMed ID: 19440027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
    Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence.
    Lee SC; Kim YJ; Kim TH; Yun SJ; Lee NK; Kim WJ
    J Urol; 2008 Feb; 179(2):570-4. PubMed ID: 18078957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass.
    Penniston KL; Kaplon DM; Gould JC; Nakada SY
    J Urol; 2009 Nov; 182(5):2340-6. PubMed ID: 19762051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the medical management of stone disease.
    Tracy CR; Pearle MS
    Curr Opin Urol; 2009 Mar; 19(2):200-4. PubMed ID: 19188774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithiasis and risk factors.
    Ferrari P; Piazza R; Ghidini N; Bisi M; Galizia G; Ferrari G
    Urol Int; 2007; 79 Suppl 1():8-15. PubMed ID: 17726346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stone formation and management after bariatric surgery.
    Tarplin S; Ganesan V; Monga M
    Nat Rev Urol; 2015 May; 12(5):263-70. PubMed ID: 25850790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and uric acid nephrolithiasis.
    Sakhaee K; Maalouf NM
    Semin Nephrol; 2008 Mar; 28(2):174-80. PubMed ID: 18359398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
    Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
    J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic syndrome and nephrolithiasis].
    Kohjimoto Y; Iba A; Sasaki Y; Hara I
    Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies on the recurrence of urolithiasis (5). Diurnal variation in urinary pH and stone compositions].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Oct; 34(10):1711-5. PubMed ID: 3245520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.